These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 1649260)

  • 1. Class II antigen expression in peripheral neuropathies.
    Mitchell GW; Williams GS; Bosch EP; Hart MN
    J Neurol Sci; 1991 Apr; 102(2):170-6. PubMed ID: 1649260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy.
    Van Rhijn I; Van den Berg LH; Bosboom WM; Otten HG; Logtenberg T
    Brain; 2000 Oct; 123 ( Pt 10)():2020-9. PubMed ID: 11004119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins.
    Mancardi GL; Cadoni A; Zicca A; Schenone A; Tabaton M; De Martini I; Zaccheo D
    Neurology; 1988 Jun; 38(6):848-51. PubMed ID: 2835707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies.
    Kiefer R; Kieseier BC; Brück W; Hartung HP; Toyka KV
    Brain; 1998 Mar; 121 ( Pt 3)():469-79. PubMed ID: 9549523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR expression in peripheral neuropathies: the role of Schwann cells, resident and hematogenous macrophages, and endoneurial fibroblasts.
    Sommer C; Schröder JM
    Acta Neuropathol; 1995; 89(1):63-71. PubMed ID: 7709733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of class II molecules in normal and pathological nerves. Immunocytochemical studies in vivo and in tissue culture.
    Scarpini E; Lisak RP; Beretta S; Velicogna M; Doronzo R; Moggio M; Jann S; Scarlato G
    Brain; 1990 Jun; 113 ( Pt 3)():659-75. PubMed ID: 2163718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies.
    Mathey EK; Pollard JD; Armati PJ
    J Neurol Sci; 1999 Feb; 163(1):47-52. PubMed ID: 10223410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoneurial edema in sural nerve may indicate recent onset inflammatory neuropathy.
    Üçeyler N; Necula G; Wagemann E; Toyka KV; Sommer C
    Muscle Nerve; 2016 May; 53(5):705-10. PubMed ID: 26439587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP.
    Sommer C; Koch S; Lammens M; Gabreels-Festen A; Stoll G; Toyka KV
    Neurology; 2005 Dec; 65(12):1924-9. PubMed ID: 16380614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy.
    Pollard JD; McCombe PA; Baverstock J; Gatenby PA; McLeod JG
    J Neuroimmunol; 1986 Dec; 13(2):123-34. PubMed ID: 3023444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies.
    Kiefer R; Dangond F; Mueller M; Toyka KV; Hafler DA; Hartung HP
    J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):362-8. PubMed ID: 10945811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy.
    Bosboom WM; Van den Berg LH; De Boer L; Van Son MJ; Veldman H; Franssen H; Logtenberg T; Wokke JH
    Neurology; 1999 Sep; 53(4):837-45. PubMed ID: 10489051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
    Busby M; Donaghy M
    J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy.
    Murata K; Dalakas MC
    Brain; 2000 Aug; 123 ( Pt 8)():1660-6. PubMed ID: 10908195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schwann cell expression of HLA-DR antigen in peripheral neuropathies.
    Cadoni A; Zicca A; Mancardi GL
    Lancet; 1986 Nov; 2(8518):1281-2. PubMed ID: 2878162
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct immunofluorescence in sural nerve biopsies.
    Schenone A; De Martini I; Tabaton M; Romagnoli P; Akkad Wattar AS; Bianchini D; Mancardi G
    Eur Neurol; 1988; 28(5):262-9. PubMed ID: 2852109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research criteria for defining patients with CIDP.
    Sander HW; Latov N
    Neurology; 2003 Apr; 60(8 Suppl 3):S8-15. PubMed ID: 12707417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Schwann cell and peripheral T-cell activation epitopes in hereditary motor and sensory neuropathy.
    Williams LL; Kissel JT; Shannon BT; Wright FS; Mendell JR
    J Neuroimmunol; 1992 Feb; 36(2-3):147-55. PubMed ID: 1370667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DR-expressing cells and T-lymphocytes in sural nerve biopsies.
    Schrøder HD; Olsson T; Solders G; Kristensson K; Link H
    Muscle Nerve; 1988 Aug; 11(8):864-70. PubMed ID: 3262825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory neuropathies.
    Hughes RA
    Baillieres Clin Neurol; 1994 Apr; 3(1):45-72. PubMed ID: 7921591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.